|
| |
Overview
Financial Highlight
HeadlinesBusiness Background Nova Wellness Group Bhd is engaged in providing dietary supplements which include vitamin, mineral, and herbal supplements, functional food products under brand name activmax and sustinex, and skincare products sold under brands novavis and SP8.
 Be the first to like this.   NPRA1985 UAE says Sinopharm vaccine has 86% efficacy against COVID-19 DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there. The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups. The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency. “The analysis shows no serious safety concerns,” it said. It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial. https://www.reuters.com/article/health-coronavirus-emirates/update-1-uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSL1N2IP09V 09/12/2020 3:26 PM NPRA1985 United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19 TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial. The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine. The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided. The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.” The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization. https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595c 09/12/2020 10:28 PM NPRA1985 Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing. “The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people. “Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed. SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there. https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the-arm/ 11/12/2020 12:03 AM shortinvestor77 On behalf of the Board, Kenanga IB wishes to inform that Bursa Securities had, vide its letter dated 19 January 2021, approved the Transfer under the “Health Care” sector. The Transfer will take effect immediately two (2) market days upon the announcement to Bursa Securities on the transfer date via Bursa Link. This announcement is dated 20 January 2021. https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3122541 21/01/2021 8:36 AM donkeycharles so there's another announcement, and then have to wait for 2 days then only transfer to main board? 07/02/2021 3:28 PM donkeycharles if i sell my shares tmr on ex date, am i still entitled for the div? 24/02/2021 10:16 PM sell Only Sinovac vaccine approved by NPRA and Pharmaniaga allowed to distribute not Nova Un Well. Posted by donkeycharles > Jan 29, 2021 1:56 PM | Report Abuse any news on hepar p clinical trials? 02/03/2021 11:15 PM sell Bursa is not strict enough such that many conmen successful con many ikan bilis. 02/03/2021 11:31 PM sell Shareholders just go to tiih for instance to view signed contracts and photos of signing also cannot meh? 02/03/2021 11:35 PM shortinvestor77 Once third trial test on hepar passes after a few years, it will add much value to Nova. 09/05/2021 8:55 PM Moneycometome Anyone knows Nova's new plant latest news? Is it already commissioning or still in construction? 10/09/2021 12:56 AM catalan The Board of Directors of Nova Wellness Group Berhad wishes to announce the positive results from the recently completed Hepar-P clinical trial to assess its efficacy and safety in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). 09/11/2021 9:11 PM Moneycometome Yesterday 22/11 saw Nova's truck running on Kepong road. Haha good sign to continue hold it 23/11/2021 1:04 AM | |
